{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T22:23:43Z","timestamp":1783981423149,"version":"3.55.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.bbi.2015.07.002","type":"journal-article","created":{"date-parts":[[2015,7,8]],"date-time":"2015-07-08T01:06:17Z","timestamp":1436317577000},"page":"314-321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Mast cell activation disease: An underappreciated cause of neurologic and psychiatric symptoms and diseases"],"prefix":"10.1016","volume":"50","author":[{"given":"Lawrence B.","family":"Afrin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"P\u00f6hlau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Raithel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Haenisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz L.","family":"Dumoulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Homann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe M.","family":"Mauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Harzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard J.","family":"Molderings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2015.07.002_b0005","doi-asserted-by":"crossref","unstructured":"Afrin, L.B., Molderings, G.J., 2014. A concise, practical guide to diagnostic assessment for mast cell activation disease. World J. Hematol. 3 (1) 1\u201317. http:\/\/dx.doi.org\/10.5315\/wjh.v3.i1.1. Available at: <http:\/\/www.wjgnet.com\/2218-6204\/pdf\/v3\/i1\/1.pdf>.","DOI":"10.5315\/wjh.v3.i1"},{"key":"10.1016\/j.bbi.2015.07.002_b0010","unstructured":"Afrin, L., 2013. Presentation, diagnosis, and management of mast cell activation syndrome. In: Mast Cells: Phenotypic Features, Biological Functions, and Role in Immunity. Nova Science Publishers, Happauge, NY, pp. 155\u2013231. Available at: <https:\/\/www.novapublishers.com\/catalog\/product_info.php?products_id=42603> (accessed 14.06.15)."},{"key":"10.1016\/j.bbi.2015.07.002_b0015","doi-asserted-by":"crossref","first-page":"e48934","DOI":"10.1371\/journal.pone.0048934","article-title":"Neurotensin and CRH interactions augment human mast cell activation","volume":"7","author":"Alysandratos","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2015.07.002_b0020","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1468-2982.2004.00852.x","article-title":"Headache in systemic mastocytosis: a case report with pathophysiological considerations","volume":"25","author":"Ashina","year":"2004","journal-title":"Cephalalgia"},{"key":"10.1016\/j.bbi.2015.07.002_b0025","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2982.2005.00685.x","article-title":"Functional gastrointestinal disorders and mast cells: implications for therapy","volume":"18","author":"Barbara","year":"2006","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.bbi.2015.07.002_b0030","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/pgp.0b013e318140021b","article-title":"Involvement of heparanase in the pathogenesis of localized vulvodynia","volume":"27","author":"Bornstein","year":"2008","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.bbi.2015.07.002_b0035","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/jpi.12075","article-title":"The role of melatonin in the cells of the innate immunity: a review","volume":"55","author":"Calvo","year":"2013","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.bbi.2015.07.002_b0040","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.molimm.2014.03.001","article-title":"Mast cells: versatile gatekeepers of pain","volume":"63","author":"Chatterjea","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bbi.2015.07.002_b0045","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1476-5381.1980.tb07919.x","article-title":"Inhibition of histamine release from human lung in vitro by antihistamines and related drugs","volume":"69","author":"Church","year":"1980","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbi.2015.07.002_b0050","doi-asserted-by":"crossref","first-page":"e60529","DOI":"10.1371\/journal.pone.0060529","article-title":"Perineural mast cells are specifically enriched in pancreatic neuritis and neuropathic pain in pancreatic cancer and chronic pancreatitis","volume":"8","author":"Demir","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2015.07.002_b0055","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bbr.2009.12.045","article-title":"Neuronal histamine and the interplay of memory, reinforcement and emotions","volume":"215","author":"Dere","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbi.2015.07.002_b0060","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jneuroim.2005.08.008","article-title":"Differential effects of two analgesic drugs, morphine chlorhydrate and acetylsalicylic acid, on thalamic mast cell numbers in rat","volume":"169","author":"Dubayle","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2015.07.002_b0065","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0029-1245707","article-title":"Evidence for mast cell activation in patients with therapy-resistant irritable bowel syndrome","volume":"49","author":"Frieling","year":"2011","journal-title":"Z. Gastroenterol."},{"key":"10.1016\/j.bbi.2015.07.002_b0070","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.brainresbull.2012.09.003","article-title":"Emotional memory consolidation impairment induced by histamine is mediated by H1 but not H2 receptors","volume":"89","author":"Gianloren\u00e7o","year":"2012","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbi.2015.07.002_b0075","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1111\/j.1471-4159.1985.tb07191.x","article-title":"Rat brain mast cells: contribution to brain histamine levels","volume":"44","author":"Goldschmidt","year":"1985","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbi.2015.07.002_b0080","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fimmu.2012.00120","article-title":"Mast cell: an emerging partner in immune interaction","volume":"3","author":"Gri","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2015.07.002_b0085","first-page":"495","article-title":"The therapeutic potential of cannabis and cannabinoids","volume":"109","author":"Grotenhermen","year":"2012","journal-title":"Dtsch. Arztebl. Int."},{"key":"10.1016\/j.bbi.2015.07.002_b0090","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2567.2012.03627.x","article-title":"Systemic mast cell activation disease: the role of molecular genetic alterations in pathogenesis, heritability and diagnostics","volume":"137","author":"Haenisch","year":"2012","journal-title":"Immunology"},{"key":"10.1016\/j.bbi.2015.07.002_b0095","doi-asserted-by":"crossref","first-page":"e2266","DOI":"10.1371\/journal.pone.0002266","article-title":"Case\u2013control cohort study of patients\u2019 perceptions of disability in mastocytosis","volume":"3","author":"Hermine","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2015.07.002_b0100","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jpainsymman.2003.09.005","article-title":"Clonazepam as an adjuvant analgesic in patients with cancer-related neuropathic pain","volume":"26","author":"Hugel","year":"2003","journal-title":"J. Pain Symptom Manage."},{"key":"10.1016\/j.bbi.2015.07.002_b0105","unstructured":"Ibelgaufts, H., 2015. Mast cells. In: COPE: Cytokines and Cells Online Pathfinder Encyclopaedia. Available at: <http:\/\/www.copewithcytokines.de\/cope.cgi?key=mast%20cells> (accessed 4.02.15)."},{"key":"10.1016\/j.bbi.2015.07.002_b0110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1540\/jsmr.44.83","article-title":"Nerve-mast cell and smooth muscle-mast cell interaction mediated by cell adhesion molecule-1, CADM1","volume":"44","author":"Ito","year":"2008","journal-title":"J. Smooth Muscle Res."},{"key":"10.1016\/j.bbi.2015.07.002_b0115","doi-asserted-by":"crossref","first-page":"C138","DOI":"10.1152\/ajpcell.1994.267.1.C138","article-title":"Picomolar doses of substance P trigger electrical responses in mast cells without degranulation","volume":"267","author":"Janiszewski","year":"1994","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbi.2015.07.002_b0120","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1248\/bpb.34.1170","article-title":"Prostaglandin E2 and pain \u2013 an update","volume":"34","author":"Kawabata","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bbi.2015.07.002_b0125","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainres.2007.07.034","article-title":"Brain mast cell relationship to neurovasculature during development","volume":"1171","author":"Khalil","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2015.07.002_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2005.07.026","article-title":"Mast cells modulate maintained neuronal activity in the thalamus in vivo","volume":"171","author":"Kovacs","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2015.07.002_b0135","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1365-2567.2007.02705.x","article-title":"Neuropeptides activate human mast cell degranulation and chemokine production","volume":"123","author":"Kulka","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.bbi.2015.07.002_b0140","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1365-2362.2008.02047.x","article-title":"Clinical correlates of blood serotonin levels in patients with mastocytosis","volume":"38","author":"Kushnir-Sukhov","year":"2008","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.bbi.2015.07.002_b0145","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0014-2999(02)02947-3","article-title":"Combined action of vasoactive amines and bradykinin mediates allergen-evoked thermal hyperalgesia in rats","volume":"462","author":"Lavich","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbi.2015.07.002_b0150","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.bbi.2011.09.016","article-title":"Mast cell degranulation distinctly activates trigemino-cervical and lumbosacral pain pathways and elicits widespread tactile pain hypersensitivity","volume":"26","author":"Levy","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2015.07.002_b0155","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/205873920601900102","article-title":"Fibromyalgia \u2013 new concepts of pathogenesis and treatment","volume":"19","author":"Lucas","year":"2006","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.bbi.2015.07.002_b0160","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00018-010-0587-0","article-title":"Biological implications of preformed mast cell mediators","volume":"68","author":"Lundequist","year":"2011","journal-title":"Cell Mol Life Sci."},{"key":"10.1016\/j.bbi.2015.07.002_b0165","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1398-9995.2011.02550.x","article-title":"Neuropeptide blood levels correlate with mast cell load in patients with mastocytosis","volume":"66","author":"Maintz","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.bbi.2015.07.002_b0170","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.phrs.2009.11.014","article-title":"Evidence of melatonin synthesis and release by mast cells. Possible modulatory role on inflammation","volume":"62","author":"Maldonado","year":"2010","journal-title":"Pharmacol. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.bbi.2015.07.002_b0175","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1007\/s00011-004-0406-x","article-title":"Post-infectional distribution and phenotype of mast cells penetrating human brains","volume":"54","author":"Ma\u015bli\u0144ska","year":"2005","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.bbi.2015.07.002_b0180","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.neubiorev.2008.10.005","article-title":"Evidence for a cytokine model of cognitive function","volume":"33","author":"McAfoose","year":"2009","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2015.07.002_b0185","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.critrevonc.2014.09.001","article-title":"The genetic basis of mast cell activation disease \u2013 looking through a glass darkly","volume":"93","author":"Molderings","year":"2015","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bbi.2015.07.002_b0190","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/00365520701245744","article-title":"Multiple novel alterations in Kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder","volume":"42","author":"Molderings","year":"2007","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.bbi.2015.07.002_b0195","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00251-010-0474-8","article-title":"Comparative analysis of mutation of tyrosine kinase Kit in mast cells from patients with systemic mast cell activation syndrome and healthy subjects","volume":"62","author":"Molderings","year":"2010","journal-title":"Immunogenetics"},{"key":"10.1016\/j.bbi.2015.07.002_b0200","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1756-8722-4-10","article-title":"Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options","volume":"4","author":"Molderings","year":"2011","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbi.2015.07.002_b0205","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2169\/internalmedicine.50.4640","article-title":"Omalizumab treatment of systemic mast cell activation disease: experiences from four cases","volume":"50","author":"Molderings","year":"2011","journal-title":"Intern. Med."},{"key":"10.1016\/j.bbi.2015.07.002_b0210","doi-asserted-by":"crossref","first-page":"e76241","DOI":"10.1371\/journal.pone.0076241","article-title":"Familial occurrence of systemic mast cell activation disease","volume":"8","author":"Molderings","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2015.07.002_b0215","doi-asserted-by":"crossref","first-page":"R595","DOI":"10.1152\/ajpregu.90888.2008","article-title":"Mast cells are necessary for the hypothermic response to LPS-induced sepsis","volume":"296","author":"Nautiyal","year":"2009","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.bbi.2015.07.002_b0220","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00401-013-1092-y","article-title":"The role of mast cells in neuroinflammation","volume":"125","author":"Nelissen","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbi.2015.07.002_b0225","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1742-481X.2009.00651.x","article-title":"The role of mast cells in wound healing","volume":"7","author":"Ng","year":"2010","journal-title":"Int. Wound J."},{"key":"10.1016\/j.bbi.2015.07.002_b0230","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.biocel.2006.11.016","article-title":"Pain signalling pathways: from cytokines to ion channels","volume":"39","author":"Okuse","year":"2007","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"10.1016\/j.bbi.2015.07.002_b0235","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/0306-4522(95)00606-0","article-title":"Definitive characterization of rat hypothalamic mast cells","volume":"73","author":"Pang","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbi.2015.07.002_b0240","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1182\/blood-2012-12-469882","article-title":"Increased circulating levels of neurotrophins and elevated expression of their high-affinity receptors on skin and gut mast cells in mastocytosis","volume":"122","author":"Peng","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbi.2015.07.002_b0245","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/stem.523","article-title":"Adipose tissue as a dedicated reservoir of functional mast cell progenitors","volume":"28","author":"Poglio","year":"2010","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbi.2015.07.002_b0250","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1469-7580.2004.00256.x","article-title":"The distribution of mast cells in the human area postrema","volume":"204","author":"Porzionato","year":"2004","journal-title":"J. Anat."},{"key":"10.1016\/j.bbi.2015.07.002_b0255","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archpsyc.58.5.445","article-title":"Cytokine-associated emotional and cognitive disturbances in humans","volume":"58","author":"Reichenberg","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbi.2015.07.002_b0260","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0165-5728(98)00137-4","article-title":"Brain mast cells lack the c-kit receptor: immunocytochemical evidence","volume":"90","author":"Shanas","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2015.07.002_b0265","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.tins.2013.06.001","article-title":"Mast cells on the mind: new insights and opportunities","volume":"36","author":"Silver","year":"2013","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbi.2015.07.002_b0270","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.clineuro.2011.05.002","article-title":"Neurologic symptoms and diagnosis in adults with mast cell disease","volume":"113","author":"Smith","year":"2011","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.bbi.2015.07.002_b0275","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-065X.2007.00519.x","article-title":"Differential release of mast cell mediators and the pathogenesis of inflammation","volume":"217","author":"Theoharides","year":"2007","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbi.2015.07.002_b0280","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s11055-005-0144-8","article-title":"Characteristics of mast cells in the choroid plexus of the ventricles of the human brain in aging","volume":"35","author":"Turygin","year":"2005","journal-title":"Neurosci. Behav. Physiol."},{"key":"10.1016\/j.bbi.2015.07.002_b0285","series-title":"World Health Organization (WHO) Classification of Tumours. Pathology and Genetics. Tumours of Haematopoietic and Lymphoid Tissues","first-page":"291","article-title":"Mastocytosis","author":"Valent","year":"2001"},{"key":"10.1016\/j.bbi.2015.07.002_b0290","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria","volume":"37","author":"Valent","year":"2007","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.bbi.2015.07.002_b0295","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","article-title":"Definitions, criteria, and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal","volume":"157","author":"Valent","year":"2012","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.bbi.2015.07.002_b0300","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejphar.2008.01.003","article-title":"Histaminergic system of the lateral septum in the modulation of anxiety-like behaviour in rats","volume":"583","author":"Zarrindast","year":"2008","journal-title":"Eur. J. Pharmacol."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159115002366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159115002366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:42:37Z","timestamp":1760168557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159115002366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":60,"alternative-id":["S0889159115002366"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2015.07.002","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mast cell activation disease: An underappreciated cause of neurologic and psychiatric symptoms and diseases","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2015.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}